Skip to content

A Study on the Role of Anesthesia-specific Nasal Mask Oxygen Therapy in Oxygen-therapeutics for Patients with Acute Hypoxemic Respiratory Failure

A Study on the Role of Anesthesia-specific Nasal Mask Oxygen Therapy in Oxygen-therapeutics for Patients with Acute Hypoxemic Respiratory Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101850
Enrollment
Unknown
Registered
2025-04-30
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute hypoxic respiratory failure

Interventions

Control group:Receiving nasal high-flow oxygen therapy (HFNO)
Experimental group:Oxygen is given with a nasal mask for anesthesia

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Age>=18 years; 2) respiratory rate > 25 breaths/min, or accompanied by acute onset (<1 week) respiratory distress; 3) PaO2/FiO2 < 300 mmHg or pulse oximetry (SpO2) <90% when inhaled air; 4) Patients voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Acute exacerbation of severe asthma (involving respiratory muscles) or chronic obstructive pulmonary disease; 2) history of chronic respiratory failure or moderate to severe cardiac insufficiency (New York cardiac function class greater than grade 2 or left ventricular ejection fraction less than 45%); 3) clinical evidence of cardiogenic pulmonary edema; Hemodynamic instability (systolic blood pressure 45mmHg); 5) Glasgow Coma Score <13; 6) Facial anatomy contraindications to nasal mask or nasal cannula application; 7) Pregnant or lactating patients; 8) the need for invasive mechanical ventilation (IMV) prior to the start of the study; 9) The patient is unable to cooperate with treatment or observation.

Design outcomes

Primary

MeasureTime frame
Oxygen therapy method shift rate;

Secondary

MeasureTime frame
Partial pressure of oxygen (PaO2) Heart rate (HR), oxygen saturation (SpO2), partial pressure of carbon dioxide (PaCO2);Total length of stay;Intubation rate;Dyspnea score;Adverse events;Patient Satisfaction;Time from 28 days after enrollment to clinical recovery;

Countries

China

Contacts

Public ContactWenjun Yan

Gansu Provincial Hospital

13893370700@163.com+86 138 9337 0700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026